{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:21:39Z","timestamp":1787728899243,"version":"build-2784847793"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251375-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Best-practice guidelines recommend oral medications for treating agitation in the emergency department (ED). However, there is limited study of their use in the ED, especially in the setting of drug and alcohol intoxication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the implementation of oral medications to treat agitation in an ED in which intramuscular medications were standard and to increase the use of oral medications to treat agitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This quality improvement study analyzed 2 populations. First, all ED patients in an urban level 1 adult and pediatric trauma center from January 1, 2018, to May 31, 2024, were studied to compare the preintervention and postintervention periods. Second, during the 12-month implementation period from September 16, 2020, to August 31, 2021, patients were prospectively observed in an area of the ED dedicated to caring for patients with drug and alcohol intoxication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Oral medications to treat agitation, including olanzapine and lorazepam, were encouraged via education and real-time feedback for ED staff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the proportion of patients receiving their first sedating medication via the oral route. Secondary outcomes included data on time to adequate sedation and adverse drug events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 460\u202f600 ED encounters (median patient age, 38 years [IQR, 27-55 years]; 57.8% men; 184\u202f050 [40.0%] before the intervention, 276\u202f550 [60.0%] after), the proportion of patients receiving any sedating medication was similar between time periods (11.8% before intervention vs 11.5% after). The proportion of patients receiving their first sedating medication via the oral route increased after the intervention (7.2% vs 31.4%; difference, 24.2 percentage points [pp] [95% CI, 23.6-24.8 pp]). Among 1178 patients receiving sedating medications during implementation (860 [73.0%] with alcohol intoxication; median breath or blood concentration, 0.22% [IQR, 0.16%-0.28%]), 630 (53.5%) were offered oral medication, of whom 446 (70.8%) accepted it. Time to adequate sedation was 15 minutes (IQR, 7-33 minutes) for oral and 15 minutes (IQR, 9-26 minutes) for intramuscular medications (median difference, 1 minute [95% CI, \u22120.6 to 2.6 minutes]). There were no significant differences between routes in rates of additional rescue medications (oral, 31.8%; intramuscular, 28.4%; difference, 3.4 pp [95% CI, \u22122.0 to 8.8 pp]) or adverse drug reactions (oral, 2.7%; intramuscular, 1.1%; difference, 1.6 pp [95% CI, \u22120.1 to 3.3 pp]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251375-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this quality improvement study, emergency physicians successfully adopted oral medications for treating agitation, primarily from intoxication. No difference was found in time to adequate sedation when oral or intramuscular medications were used as primary therapy. These data support best-practice guidelines that suggest oral medications should be first-line treatment for agitation in the ED.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.51683","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:30:31Z","timestamp":1767112231000},"page":"e2551683","source":"Crossref","is-referenced-by-count":5,"title":["Oral Medications for Treating Agitation in a Safety Net Emergency Department"],"prefix":"10.1001","volume":"8","author":[{"given":"Jon B.","family":"Cole","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kowsar M.","family":"Hurreh","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla A.","family":"Taghizadeh","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Laudenbach","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis D.","family":"Olives","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Miner","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"4","key":"zoi251375r1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.annemergmed.2018.06.001","article-title":"The characteristics and prevalence of agitation in an urban county emergency department.","volume":"72","author":"Miner","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi251375r2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.clinthera.2010.03.006","article-title":"Systematic reviews of assessment measures and pharmacologic treatments for agitation.","volume":"32","author":"Zeller","year":"2010","journal-title":"Clin Ther"},{"issue":"3","key":"zoi251375r3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of droperidol for sedation of acute behavioral disturbance in the emergency department.","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi251375r4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jppr.1522","article-title":"Management of behavioural emergencies: a prospective observational study in Australian emergency departments.","volume":"49","author":"Yap","year":"2019","journal-title":"J Pharm Pract Res"},{"issue":"1","key":"zoi251375r5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-Escalation Workgroup.","volume":"13","author":"Richmond","year":"2012","journal-title":"West J Emerg Med"},{"key":"zoi251375r6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ajem.2021.09.029","article-title":"The use of verbal de-escalation in intoxicated emergency department patients.","volume":"56","author":"Klein","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"1","key":"zoi251375r7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.annemergmed.2023.09.010","article-title":"Clinical policy: critical issues in the evaluation and management of adult out-of-hospital or emergency department patients presenting with severe agitation: approved by the ACEP board of directors, October 6, 2023.","volume":"83","author":"Thiessen","year":"2024","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi251375r8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/1742-6723.13173","article-title":"Impact of acutely behavioural disturbed patients in the emergency department: a prospective observational study.","volume":"31","author":"Oliver","year":"2019","journal-title":"Emerg Med Australas"},{"issue":"5","key":"zoi251375r9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jemermed.2012.01.028","article-title":"Are oral medications effective in the management of acute agitation?","volume":"43","author":"Gault","year":"2012","journal-title":"J Emerg Med"},{"issue":"1","key":"zoi251375r10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5811\/westjem.2011.9.6865","article-title":"Overview of Project BETA: best practices in evaluation and treatment of agitation.","volume":"13","author":"Holloman","year":"2012","journal-title":"West J Emerg Med"},{"issue":"1","key":"zoi251375r11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project Beta Psychopharmacology Workgroup.","volume":"13","author":"Wilson","year":"2012","journal-title":"West J Emerg Med"},{"issue":"1","key":"zoi251375r12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/pharmacy11010004","article-title":"Enhancing outcomes: acceptability of medication formulations for the treatment of acute agitation in a psychiatric population.","volume":"11","author":"Walker","year":"2022","journal-title":"Pharmacy (Basel)"},{"issue":"4","key":"zoi251375r13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jemermed.2017.04.026","article-title":"Oral medication for agitation of psychiatric origin: a scoping review of randomized controlled trials.","volume":"53","author":"Mullinax","year":"2017","journal-title":"J Emerg Med"},{"issue":"3","key":"zoi251375r14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4088\/JCP.v65n0315","article-title":"Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.","volume":"65","author":"Currier","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"zoi251375r15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000315437","article-title":"Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study.","volume":"62","author":"Lim","year":"2010","journal-title":"Neuropsychobiology"},{"issue":"4","key":"zoi251375r16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.annemergmed.2018.04.027","article-title":"Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department.","volume":"72","author":"Klein","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"2","key":"zoi251375r17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.annemergmed.2021.01.005","article-title":"A prospective study of intramuscular droperidol or olanzapine for acute agitation in the emergency department: a natural experiment owing to drug shortages.","volume":"78","author":"Cole","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi251375r18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0196-0644(87)80179-8","article-title":"Haloperidol for sedation of disruptive emergency patients.","volume":"16","author":"Clinton","year":"1987","journal-title":"Ann Emerg Med"},{"issue":"2","key":"zoi251375r19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.annemergmed.2023.08.009","article-title":"Factors associated with physical restraint in an urban emergency department.","volume":"83","author":"Robinson","year":"2024","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi251375r22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1197\/aemj.9.4.300","article-title":"Health care utilization of chronic inebriates.","volume":"9","author":"Thornquist","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"12","key":"zoi251375r23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"9","key":"zoi251375r25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1553-2712.1996.tb03530.x","article-title":"The frequency of unsuspected minor illness or injury in intoxicated patients.","volume":"3","author":"Biros","year":"1996","journal-title":"Acad Emerg Med"},{"issue":"3","key":"zoi251375r26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.annemergmed.2017.07.021","article-title":"Unsuspected critical illness among emergency department patients presenting for acute alcohol intoxication.","volume":"71","author":"Klein","year":"2018","journal-title":"Ann Emerg Med"},{"key":"zoi251375r27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ajem.2020.12.079","article-title":"Medical needs of emergency department patients presenting with acute alcohol and drug intoxication.","volume":"42","author":"Stang","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"2","key":"zoi251375r28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/PEC.0000000000001231","article-title":"The use, safety, and efficacy of olanzapine in a level I pediatric trauma center emergency department over a 10-year period.","volume":"36","author":"Cole","year":"2020","journal-title":"Pediatr Emerg Care"},{"issue":"10","key":"zoi251375r29","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/acem.70045","article-title":"Prevalence of violence against health care workers among agitated patients in an urban emergency department.","volume":"32","author":"Boes","year":"2025","journal-title":"Acad Emerg Med"},{"issue":"7","key":"zoi251375r30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ajem.2006.12.002","article-title":"The association of a decreased level of awareness and blood alcohol concentration with both agitation and sedation in intoxicated patients in the ED.","volume":"25","author":"Miner","year":"2007","journal-title":"Am J Emerg Med"},{"issue":"6","key":"zoi251375r31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1742-6723.2011.01484.x","article-title":"Sedation assessment tool to score acute behavioural disturbance in the emergency department.","volume":"23","author":"Calver","year":"2011","journal-title":"Emerg Med Australas"},{"issue":"10","key":"zoi251375r32","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients.","volume":"166","author":"Sessler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"zoi251375r33","first-page":"1167","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.","volume":"12","author":"Martel","year":"2005","journal-title":"Acad Emerg Med"},{"issue":"4","key":"zoi251375r34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study.","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi251375r35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.29252\/beat-060404","article-title":"Effect of intramuscular ketamine versus haloperidol on short-term control of severe agitated patients in emergency department; a randomized clinical trial.","volume":"6","author":"Heydari","year":"2018","journal-title":"Bull Emerg Trauma"},{"issue":"4","key":"zoi251375r36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/acem.14124","article-title":"Randomized double-blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department.","volume":"28","author":"Martel","year":"2021","journal-title":"Acad Emerg Med"},{"issue":"1","key":"zoi251375r37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1078390320987622","article-title":"Reducing the use of mechanical restraints in the medical-surgical department.","volume":"29","author":"Adekanmi","year":"2023","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"6","key":"zoi251375r38","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements.","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad Pediatr"},{"issue":"2","key":"zoi251375r39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/15622975.2015.1132007","article-title":"Assessment and management of agitation in psychiatry: expert consensus.","volume":"17","author":"Garriga","year":"2016","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"zoi251375r40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/YCO.0000000000000787","article-title":"Psychopharmacology of agitation in acute psychotic and manic episodes.","volume":"35","author":"Stetson","year":"2022","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"zoi251375r41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/JCP.0b013e3181db8715","article-title":"Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.","volume":"30","author":"Hsu","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"zoi251375r42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00131746-200603000-00005","article-title":"Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.","volume":"12","author":"Veser","year":"2006","journal-title":"J Psychiatr Pract"},{"issue":"3","key":"zoi251375r43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.annemergmed.2016.08.008","article-title":"A prospective observational study of patients receiving intravenous and intramuscular olanzapine in the emergency department.","volume":"69","author":"Cole","year":"2017","journal-title":"Ann Emerg Med"},{"key":"zoi251375r45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00131746-200511001-00002","article-title":"The expert consensus guideline series: treatment of behavioral emergencies 2005.","volume":"11","author":"Allen","year":"2005","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"zoi251375r46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.genhosppsych.2008.03.004","article-title":"Olanzapine orally disintegrating tablet vs risperidone oral solution in the treatment of acutely agitated psychotic patients.","volume":"30","author":"Hatta","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi251375r47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajem.2020.07.013","article-title":"Intramuscular medication for treatment of agitation in the emergency department: a systematic review of controlled trials.","volume":"46","author":"Schneider","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"1","key":"zoi251375r48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial.","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"zoi251375r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100751","article-title":"Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: a multi-centre, double-blind, randomised clinical trial.","volume":"32","author":"Chan","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"3","key":"zoi251375r50","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial.","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi251375r51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.annemergmed.2018.05.025","article-title":"Ethics and regulatory barriers to research in emergency settings.","volume":"72","author":"Dickert","year":"2018","journal-title":"Ann Emerg Med"},{"issue":"5","key":"zoi251375r52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/acem.13673","article-title":"Study enrollment when \u201cpreconsent\u201d is utilized for a randomized clinical trial of two treatments for acute agitation in the emergency department.","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"issue":"1","key":"zoi251375r53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajem.2017.06.043","article-title":"A brief assessment of capacity to consent instrument in acutely intoxicated emergency department patients.","volume":"36","author":"Martel","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"5","key":"zoi251375r54","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/emp2.12138","article-title":"Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation).","volume":"1","author":"Roppolo","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"2","key":"zoi251375r55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/inm.12654","article-title":"The effectiveness of chemical restraint in managing acute agitation and aggression: a systematic review of randomized controlled trials.","volume":"29","author":"Muir-Cochrane","year":"2020","journal-title":"Int J Ment Health Nurs"},{"issue":"2","key":"zoi251375r56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/10903127.2024.2361133","article-title":"Feasibility and safety of oral risperidone to treat prehospital agitation.","volume":"29","author":"Simpson","year":"2025","journal-title":"Prehosp Emerg Care"},{"issue":"4","key":"zoi251375r57","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/1742-6723.13219","article-title":"Methamphetamine presentations to an emergency department: management and complications.","volume":"31","author":"Isoardi","year":"2019","journal-title":"Emerg Med Australas"},{"issue":"9","key":"zoi251375r58","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1111\/jgs.19485","article-title":"Comparative safety of medications for severe agitation: a Geriatric Emergency Department Guidelines 2.0 systematic review.","volume":"73","author":"Casey","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"zoi251375r20","unstructured":"US Centers for Disease Control and Prevention. Data on excessive alcohol use. August 6, 2024. Accessed May 27, 2025. https:\/\/www.cdc.gov\/alcohol\/excessive-drinking-data\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/alcohol\/data-stats.htm"},{"key":"zoi251375r21","unstructured":"Stat? M. 340A.902 DRUNKENNESS NOT A CRIME (2024). Accessed November 21, 2025. https:\/\/www.revisor.mn.gov\/statutes\/cite\/340a.902"},{"key":"zoi251375r24","unstructured":"Hennepin Healthcare Research Institute. Human research protection criteria for QA\/QI determinations. Accessed March 25, 2024. https:\/\/www.hhrinstitute.org\/wp-content\/uploads\/199-GUIDANCE-QA-QI-activities.pdf"},{"key":"zoi251375r44","unstructured":"Olanzapine. Prescribing information. US Food and Drug Administration. 2009. Accessed December 8, 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/020592s062021086s040021253s048lbl.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843234\/cole_2025_oi_251375_1766090488.29605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:30:32Z","timestamp":1767112232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.51683","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}